261 related articles for article (PubMed ID: 28379375)
1. Clinical, Serological, and Virological Analysis of 572 Chikungunya Patients From 2010 to 2013 in India.
Jain J; Nayak K; Tanwar N; Gaind R; Gupta B; Shastri JS; Bhatnagar RK; Kaja MK; Chandele A; Sunil S
Clin Infect Dis; 2017 Jul; 65(1):133-140. PubMed ID: 28379375
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of chikungunya virus infection in children from India during 2009-2010: A cross sectional observational study.
Raghavendhar BS; Ray P; Ratagiri VH; Sharma BS; Kabra SK; Lodha R
J Med Virol; 2016 Jun; 88(6):923-30. PubMed ID: 26581026
[TBL] [Abstract][Full Text] [Related]
3. Correlation of plasma viral loads and presence of Chikungunya IgM antibodies with cytokine/chemokine levels during acute Chikungunya virus infection.
Reddy V; Mani RS; Desai A; Ravi V
J Med Virol; 2014 Aug; 86(8):1393-401. PubMed ID: 24523146
[TBL] [Abstract][Full Text] [Related]
4. Re-emergence of Chikungunya virus infection in Eastern India.
Sengupta S; Mukherjee S; Haldar SK; Bhattacharya N; Tripathi A
Braz J Microbiol; 2020 Mar; 51(1):177-182. PubMed ID: 31898249
[TBL] [Abstract][Full Text] [Related]
5. Copy number variation of Chikungunya ECSA virus with disease symptoms among Indian patients.
Dutta SK; Pal T; Saha B; Mandal S; Tripathi A
J Med Virol; 2014 Aug; 86(8):1386-92. PubMed ID: 24132555
[TBL] [Abstract][Full Text] [Related]
6. Chikungunya Outbreaks in India: A Prospective Study Comparing Neutralization and Sequelae during Two Outbreaks in 2010 and 2016.
Jain J; Kaur N; Haller SL; Kumar A; Rossi SL; Narayanan V; Kumar D; Gaind R; Weaver SC; Auguste AJ; Sunil S
Am J Trop Med Hyg; 2020 Apr; 102(4):857-868. PubMed ID: 32067624
[TBL] [Abstract][Full Text] [Related]
7. Laboratory surveillance of chikungunya in Madhya Pradesh, India (2016-2017).
Joshi P; Yadav P; Mourya D; Sahare L; Ukey M; Khedekar R; Patil D; Barde PV
Indian J Med Res; 2020 Jan; 151(1):87-92. PubMed ID: 32134019
[TBL] [Abstract][Full Text] [Related]
8. Hidden burden of chikungunya in North India; A prospective study in a tertiary care centre.
Dinkar A; Singh J; Prakash P; Das A; Nath G
J Infect Public Health; 2018; 11(4):586-591. PubMed ID: 28993172
[TBL] [Abstract][Full Text] [Related]
9. Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary Assessment.
Olajiga OM; Adesoye OE; Emilolorun AP; Adeyemi AJ; Adeyefa EO; Aderibigbe IA; Adejumo SA; Adebimpe WO; Opaleye OO; Sule WF; Oluwayelu DO
Immunol Invest; 2017 Aug; 46(6):552-565. PubMed ID: 28742401
[TBL] [Abstract][Full Text] [Related]
10. Chikungunya infection in India: results of a prospective hospital based multi-centric study.
Ray P; Ratagiri VH; Kabra SK; Lodha R; Sharma S; Sharma BS; Kalaivani M; Wig N
PLoS One; 2012; 7(2):e30025. PubMed ID: 22363413
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of dengue and chikungunya virus strains circulating in New Delhi, India.
Afreen N; Deeba F; Khan WH; Haider SH; Kazim SN; Ishrat R; Naqvi IH; Shareef MY; Broor S; Ahmed A; Parveen S
Microbiol Immunol; 2014 Dec; 58(12):688-96. PubMed ID: 25346397
[TBL] [Abstract][Full Text] [Related]
12. A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial.
Folegatti PM; Harrison K; Preciado-Llanes L; Lopez FR; Bittaye M; Kim YC; Flaxman A; Bellamy D; Makinson R; Sheridan J; Azar SR; Campos RK; Tilley M; Tran N; Jenkin D; Poulton I; Lawrie A; Roberts R; Berrie E; Rossi SL; Hill A; Ewer KJ; Reyes-Sandoval A
Nat Commun; 2021 Jul; 12(1):4636. PubMed ID: 34330906
[TBL] [Abstract][Full Text] [Related]
13. Estimating the seroprevalence of chikungunya virus exposure in Shimoga district, Karnataka state: A hospital-based study during 2014-2018.
Shilpa C; Kavitha K; Sudheesh N; Sabeena S; Prasad V; Hindol M; Arunkumar G
J Med Virol; 2020 Jan; 92(1):119-123. PubMed ID: 31463940
[TBL] [Abstract][Full Text] [Related]
14. Pre-existing chikungunya virus neutralizing antibodies correlate with risk of symptomatic infection and subclinical seroconversion in a Philippine cohort.
Yoon IK; Srikiatkhachorn A; Alera MT; Fernandez S; Cummings DAT; Salje H
Int J Infect Dis; 2020 Jun; 95():167-173. PubMed ID: 32247051
[TBL] [Abstract][Full Text] [Related]
15. Chikungunya virus RNA and antibody testing at a National Reference Laboratory since the emergence of Chikungunya virus in the Americas.
Prince HE; Seaton BL; Matud JL; Batterman HJ
Clin Vaccine Immunol; 2015 Mar; 22(3):291-7. PubMed ID: 25540275
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of Chikungunya dominated co-infection with dengue during an outbreak in south India (2010 and 2012).
Venkatasubramani K; Paramasivan R; Thenmozhi V; Dhananjeyan KJ; Balaji T; Leo SV
Trop Doct; 2015 Jul; 45(3):197-9. PubMed ID: 25990548
[TBL] [Abstract][Full Text] [Related]
17. Antibody response patterns in chikungunya febrile phase predict protection versus progression to chronic arthritis.
Nayak K; Jain V; Kaur M; Khan N; Gottimukkala K; Aggarwal C; Sagar R; Gupta S; Rai RC; Dixit K; Islamuddin M; Khan WH; Verma A; Maheshwari D; Chawla YM; Reddy ES; Panda H; Sharma P; Bhatnagar P; Singh P; Raghavendhar B S; Patel AK; Ratageri VH; Chandele A; Ray P; Murali-Krishna K
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32155134
[TBL] [Abstract][Full Text] [Related]
18. Age-Dependent Evaluation of Immunoglobulin G Response after Chikungunya Virus Infection.
Patil HP; Gosavi M; Mishra AC; Arankalle VA
Am J Trop Med Hyg; 2021 Feb; 104(4):1438-1443. PubMed ID: 33617471
[TBL] [Abstract][Full Text] [Related]
19. Persistent arthralgia among Chikungunya patients and associated risk factors in Chennai, South India.
Ramachandran V; Kaur P; Kanagasabai K; Vadivoo S; Murhekar MV
J Postgrad Med; 2014; 60(1):3-6. PubMed ID: 24625931
[TBL] [Abstract][Full Text] [Related]
20. Disease Resolution in Chikungunya-What Decides the Outcome?
Srivastava P; Kumar A; Hasan A; Mehta D; Kumar R; Sharma C; Sunil S
Front Immunol; 2020; 11():695. PubMed ID: 32411133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
